UNITED STATES, September 4, 2026 — DBM Aesthetics announced the expansion of its Luchel Skin Booster provider education program, introducing updated guidance covering product preparation, topical application, ingredient roles, safety considerations, client screening, and integration into professional aesthetic treatment workflows.

The update follows increased provider interest in professional skin hydration services and growing confusion between topical skin boosters, injectable products, dermal fillers, and biostimulators. DBM Aesthetics developed the expanded resource to clarify intended use and provide clinics with a more structured framework for incorporating Luchel into non-injectable skin care protocols.

“Providers need clear information about how a product is intended to be prepared, applied, and incorporated into an aesthetic practice,” said Daniel Lee, President and General Manager of DBM Corporation USA. “The expanded Luchel education resource is designed to support consistent handling, realistic product positioning, and better differentiation between topical skin care and injectable treatment categories.”

The Luchel Skin Booster education program outlines the product’s dual-vial preparation process. Luchel combines a vial containing fully solubilized mPEG PDLLA with a liquid component containing hyaluronic acid, polynucleotide, and proteoglycan. Providers mix the components immediately before topical application, with no specialized mixing equipment required.

Updated protocols emphasize that Luchel is intended for topical application only. The resource specifically distinguishes Luchel from injectable skin boosters, dermal fillers, and injectable collagen stimulators and advises providers not to inject the product or use it as a delivery material through microneedling channels.

The program also introduces structured client-screening guidance addressing active irritation, open wounds, infection, recent procedures, known sensitivities, and incomplete skin healing. Clinics are encouraged to document product lot information, treatment response, storage conditions, preparation procedures, and any unexpected reactions as part of routine product-handling workflows.

DBM Aesthetics also expanded guidance for clinics integrating Luchel into standalone hydration treatments and professional facial protocols. Common use cases include clients seeking support for surface dryness, rough-looking texture, reduced suppleness, or a more hydrated appearance without an injectable procedure.

Provider materials further clarify the cosmetic roles of Luchel’s primary ingredients. Hyaluronic acid is positioned as a moisture-binding component, while polynucleotide and proteoglycan are described as conditioning ingredients. The guidance avoids extending evidence from injectable products to Luchel’s topical formulation and emphasizes realistic cosmetic expectations.

Additional operational recommendations cover staff training, product storage, packaging inspection, contraindication review, topical application, aftercare documentation, and adverse-reaction reporting. The framework is designed to help medical spas establish consistent internal protocols when adding professional hydration services to existing treatment menus.

DBM Aesthetics will continue expanding its provider education and product-support resources as professional skin care technologies, regulatory considerations, and aesthetic practice workflows continue to evolve across the United States.

Media Contact

DBM Aesthetics
Email: info@dbmcorpusa.com
Website: DBM Aesthetics

About DBM Aesthetics

DBM Aesthetics is the U.S. subsidiary of DongBang Medical and serves as a portfolio and distribution platform for medical and aesthetic products in the United States. Its product portfolio includes PDO threads, injection accessories, professional hair wellness products, skin boosters, and provider education resources.

Contact Information:

DB Medical Corporation

23263 Madero Suite B
Mission Viejo, CA 92691
United States

Daniel Lee
(949) 329-8124
https://dbmcorpusa.com/